Editorial information aggregated from public sources. Not regulated investment advice.

All founders
FounderVerified

David Norwood

Founder and first CEO of IP2IPO Group plc (now IP Group plc); as CEO of City stockbroker Beeson Gregory, he structured the founding deal with Oxford University's Chemistry Department in 2001.

David Norwood founded IP2IPO Group plc in 2001, while serving as CEO of City stockbroker Beeson Gregory (having sold his prior firm, IndexIT Partnership Ltd, to Beeson Gregory Group plc in March 2000 for approximately GBP 34 million). He negotiated IP2IPO's founding 15-year agreement with Oxford University's Chemistry Department, giving the company 50% of equity and licensing income from the department's spinouts, a model the firm later extended to other UK universities. He stepped down from IP Group (as it was renamed) in 2008. He went on to found or co-found several other ventures, including Oxford Nanopore Technologies, 4D Pharma, Aura Capital, and Synergen, and co-founded and served as CEO (2015-2019) of Oxford Sciences Innovation, later renamed Oxford Science Enterprises.

Overview

Role
Founder & CEO, IP2IPO Group plc / IP Group plc (2001-2008)
Based in
Oxford, UK
Prior experience
Bankers Trust; Duncan Lawrie; IndexIT Partnership; Beeson Gregory; Oxford Sciences Innovation

Companies1

Affiliated funds0

No linked records yet.

Frequently asked

Who is David Norwood?
David Norwood founded IP2IPO Group plc in 2001, while serving as CEO of City stockbroker Beeson Gregory (having sold his prior firm, IndexIT Partnership Ltd, to Beeson Gregory Group plc in March 2000 for approximately GBP 34 million). He negotiated IP2IPO's founding 15-year agreement with Oxford University's Chemistry Department, giving the company 50% of equity and licensing income from the department's spinouts, a model the firm later extended to other UK universities. He stepped down from IP Group (as it was renamed) in 2008. He went on to found or co-found several other ventures, including Oxford Nanopore Technologies, 4D Pharma, Aura Capital, and Synergen, and co-founded and served as CEO (2015-2019) of Oxford Sciences Innovation, later renamed Oxford Science Enterprises.
What is David Norwood's role?
David Norwood is Founder & CEO, IP2IPO Group plc / IP Group plc (2001-2008), based in Oxford, UK.
Where did David Norwood work before?
David Norwood's prior roles include Bankers Trust; Duncan Lawrie; IndexIT Partnership; Beeson Gregory; Oxford Sciences Innovation.

Tags

Sources & citations4

Each claim links to its underlying source. Confidence reflects how directly the source supports the claim.

  1. 1

    David Norwood founded IP2IPO Group plc in 2001 while CEO of Beeson Gregory, structuring the founding agreement with Oxford University's Chemistry Department; stepped down from IP Group in 2008.

    Wikipedia: David Norwood (businessman)
    Verified2026-08-15
  2. 2

    David Norwood profile describing his founding of IP2IPO/IP Group and subsequent ventures, including Oxford Sciences Innovation.

    Oxford Alumni (University of Oxford): Dave Norwood
    Verified2018-06-13
  3. 3

    David Norwood founded IP2IPO Group plc in 2001 while CEO of Beeson Gregory, structuring the founding agreement with Oxford University's Chemistry Department; stepped down from IP Group in 2008.

    Wikipedia: David Norwood (businessman)
    Verified2026-08-15
  4. 4

    David Norwood profile describing his founding of IP2IPO/IP Group and subsequent ventures, including Oxford Sciences Innovation.

    Oxford Alumni (University of Oxford): Dave Norwood
    Verified2018-06-13